ID: ALA1788159

Max Phase: Preclinical

Molecular Formula: C14H22N4NaO13P3S

Molecular Weight: 580.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCSc1ncnc2c1ncn2C1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]

Standard InChI:  InChI=1S/C14H23N4O13P3S.Na/c1-2-3-4-35-13-9-12(15-6-16-13)18(7-17-9)14-11(20)10(19)8(29-14)5-28-33(24,25)31-34(26,27)30-32(21,22)23;/h6-8,10-11,14,19-20H,2-5H2,1H3,(H,24,25)(H,26,27)(H2,21,22,23);/q;+1/p-1/t8-,10-,11-,14?;/m1./s1

Standard InChI Key:  RQDJGTZXRBQEJJ-HSXVOWMFSA-M

Associated Targets(non-human)

Adenylate kinase 3 alpha like 1 137 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 580.34Molecular Weight (Monoisotopic): 580.0195AlogP: 0.68#Rotatable Bonds: 12
Polar Surface Area: 253.11Molecular Species: ACIDHBA: 14HBD: 6
#RO5 Violations: 3HBA (Lipinski): 17HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 0.89CX Basic pKa: 3.54CX LogP: -2.77CX LogD: -7.79
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.09Np Likeness Score: 0.76

References

1. Hampton A, Kappler F, Picker D..  (1982)  Species- or isozyme-specific enzyme inhibitors. 4. Design of a two-site inhibitor of adenylate kinase with isozyme selectivity.,  25  (6): [PMID:6284937] [10.1021/jm00348a006]

Source